Details, Fiction and PXS-5153A
Listed here we clearly show that DNL343 lowers ISR activation and neurodegeneration introduced on acutely by an optic nerve crush (ONC) damage or chronically by a germline eIF2B LOF mutation in mice. We also present that DNL343 treatment, initiated at a late stage of sickness which much more correctly replicates a medical dosing paradigm, reversed